For example, the CXCR3 neutralization in mc38 tumor-bearing mice diminished the efficacy of the PD-1/PD-L1 combinatorial immunotherapy by fostering CD8+ T cell exclusion from the TME [235]. This evidence concerns the gene CD8A and neoplasm.